The Treatment Advocacy Program

Centers for Disease Control and Prevention1 site in 1 country300 target enrollmentSeptember 2004

ConditionsHIV

Overview

Phase: Phase 2
Intervention: Not specified
Conditions: HIV
Sponsor: Centers for Disease Control and Prevention
Enrollment: 300
Locations: 1
Primary Endpoint: Self-reported, unprotected (without condoms) anal or vaginal sex with HIV-negative or unknown-status partners.
Status: Completed
Last Updated: 13 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of the study is to test the efficacy of TAP, a behavioral intervention, in improving sexual safety and treatment adherence among gay and bisexual men infected with HIV. It is hypothesized that those who are in the intervention group will report reductions in unprotected sex with HIV-negative and unknown-status partners; and will show stricter adherence to their treatment regimens, compared to the individuals in the standard-of-care, control group.

Registry

clinicaltrials.gov

Start Date

September 2004

End Date

April 2008

Last Updated

13 years ago

Study Type

Interventional

Study Design

Factorial

Sex

Male

Investigators

Sponsor

Centers for Disease Control and Prevention

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•HIV+ men who have sex with other men, age 18 or over, in HIV care at one of the collaborating clinics, any sexual contact within the previous six months.

Exclusion Criteria

•self-reported low likelihood of remaining in treatment or in the study location for 12 months, inability to comprehend the consent quiz administered during the Consent and Enrollment Visit, or unwilling to provide required locator information